US EditionBelgian drugmaker UCB to invest $2B in suburban Atlanta plant, adding 330 jobs
UCB's $2 billion investment in Gwinnett County will create 330 permanent jobs and generate $5 billion in economic impact, strengthening biologics manufacturing in the U.S.
- On Tuesday, Belgium-based biopharmaceutical firm UCB announced a $2 billion investment to build a new biologics manufacturing campus in Gwinnett County, Georgia, within the Rowen innovation district.
- Strengthening its global biologics manufacturing network, UCB selected the Rowen site to support growing demand across its portfolio while building on its existing North American headquarters in Smyrna, Georgia.
- The project is expected to generate approximately $5 billion in total economic impact, with Gwinnett County committing $174 million in incentives to support more than 330 permanent highly skilled jobs.
- Governor Brian Kemp called the investment a "significant milestone," while UCB CEO Jean-Christophe Tellier stated the decision reflects "confidence in UCB's long-term growth and our deep-rooted commitment to the United States."
- Construction on the 460,000-square-foot facility is expected to take six to seven years, positioning the Rowen Foundation's campus as a hub for future life sciences collaboration in the region.
12 Articles
12 Articles
Biopharmaceutical Company To Invest $2 Billion In Manufacturing Facility, Republican Governor Announces
UCB is planning to invest $2 billion to construct a manufacturing facility near its U.S. headquarters in Atlanta, Georgia. “Governor Brian P. Kemp today announced that global biopharmaceutical giant UCB, Inc. is planning a significant investment of $2 billion in Georgia to establish its first U.S. pharmaceutical biologics manufacturing facility,” Gov. Kemp’s office stated in a release. “The investment will generate 330 new jobs over the next sev…
UCB Selects Rowen for $2B Biopharmaceutical Manufacturing Campus
First tenant milestone validates Rowen's innovation community model and signals the start of a new life sciences hub in Gwinnett County GWINNETT COUNTY, Ga., March 24, 2026 /PRNewswire/ -- The State of Georgia, Gwinnett County and the Rowen Foundation today announced that global biopharmaceutical company UCB has selected Rowen as the site of its new U.S. biologics manufacturing campus. The planned project represents a direct investment of approx…
Coverage Details
Bias Distribution
- 50% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
